Moreover, the downregulation of NKG2D was also reported in infiltrating and matched peripheral blood T cells in cancer patients with circulating tumor-derived soluble MHC class I-related chain A, suggesting this ligand can induce an impairment of the responsiveness of tumor antigen-specific effector T cells, leading to tumor escape from immunosurveillance [29]. This evidence concerns the gene MICA and neoplasm.